Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial-Reference-Cited by-同舟云学术

Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial

Published:2021-05 Issue:5 Volume:22 Page:716-726
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Lv Xing,Cao Xun,Xia Wei-Xiong,Liu Kui-Yuan,Qiang Meng-Yun,Guo Ling,Qian Chao-Nan,Cao Ka-Jia,Mo Hao-Yuan,Li Xian-Ming,Li Zi-Huang,Han Fei,He Yu-Xiang,Liu Yu-Meng,Wu Shao-Xiong,Bai Yong-Rui,Ke Liang-Ru,Qiu Wen-Ze,Liang Hu,Liu Guo-Ying,Miao Jing-Jing,Li Wang-Zhong,Lv Shu-Hui,Chen Xi,Zhao Chong,Xiang Yan-Qun,Guo Xiang

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Nasopharyngeal carcinoma;Chen;Lancet,2019

3. Time trends of nasopharyngeal carcinoma in urban Guangzhou over a 12-year period (2000-2011): declines in both incidence and mortality;Li;Asian Pac J Cancer Prev,2014

4. What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis;Ribassin-Majed;J Clin Oncol,2017

5. A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02);Frikha;Ann Oncol,2018

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma;Oral Oncology;2024-10

2. Development and application of a serious adverse events risk model for concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma;Medicine;2024-08-23

3. Anxiety and depression in nasopharyngeal carcinoma patients and network analysis to identify central symptoms: A cross-sectional study from a high-incidence area;Radiotherapy and Oncology;2024-08

4. Lobaplatin-based concurrent chemoradiotherapy in elderly nasopharyngeal carcinoma;Annals of Medicine;2024-07-31

5. Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study;BMC Medicine;2024-06-18